Bookmark and Share

Compound Summary for: CID 64627

1,3-dipropyl-8-(3-noradamantyl)xanthine

Also known as: Rolofylline; KW-3902; 1,3-Dnax; KW 3902; Rolofylline (USAN); 8-(3-Noradamantyl)-1,3-dipropylxanthine
Molecular Formula: C20H28N4O2   Molecular Weight: 356.46192   InChIKey: PJBFVWGQFLYWCB-UHFFFAOYSA-N
KW-3902 is a compounds that is under clinical development by pharmaceutical company, NovaCardia. It is used for the treatment of congestive heart failure.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _